AC Immune

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AC Immune and other ETFs, options, and stocks.

About ACIU

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

CEO

Andrea Pfeifer

CEOAndrea Pfeifer

Employees

143

Employees143

Headquarters

Lausanne, Vaud

HeadquartersLausanne, Vaud

Founded

2003

Founded2003

Employees

143

Employees143

ACIU Key Statistics

Market cap

198.85M

Market cap198.85M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

43.67K

Average volume43.67K

High today

$2.65

High today$2.65

Low today

$2.34

Low today$2.34

Open price

$2.52

Open price$2.52

Volume

59.40K

Volume59.40K

52 Week high

$8.14

52 Week high$8.14

52 Week low

$2.06

52 Week low$2.06

ACIU Earnings

-$0.30

-$0.16

-$0.03

$0.11

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 8, Pre-Market

ActualExpected Nov 8, Pre-Market